MK2870-022 TroFuse-022/ENGOT-ov84/GOG-3103: A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870- 022 TroFuse-022/ENGOT-ov84/GOG-3103)